Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders

CONCLUSIONS: The in-house CBA for MOG-Abs demonstrated reliable results and can potentially be used to evaluate CNS inflammatory disorders. A comprehensive, long-term study with a large patient population would clarify the clinical significance of MOG-Abs.PMID:37665286 | PMC:PMC10485852 | DOI:10.3343/alm.2024.44.1.56
Source: Annals of Laboratory Medicine - Category: Laboratory Medicine Authors: Source Type: research